HONG KONG, March 2 China Resources Pharmaceutical Group, a unit of state-owned conglomerate China Resources Co Ltd., has mandated three banks as sponsors of a planned Hong Kong initial public offering of at least $1 billion, IFR reported on Wednesday, citing people close to the deal.
CR Pharma, as the company is called, tapped Bank of America Merrill Lynch, CCB International and Goldman Sachs to manage the deal, added IFR, a Thomson Reuters publication.
02:18 Report: Royals, Cubs close to trading Wade Davis for Jorge Soler9
22:35 Bryce Harper's request for record $400 million deal too much for Nationals: report2
14:36 Donald Trump keeps confirming fears about his diplomatic skills28
15:14 Russia central bank: hackers stole over 2 billion roubles from accounts in central bank12